Diarylhydantoin compounds
US9896437B2 · kind B2 · utility
0Cited by
80References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 24, 2014 |
| Grant date | Feb 20, 2018 |
| Priority date | — |
| Expiry date | Mar 24, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D235/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to diarylhydantoin compounds and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.